Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →The study measured natural radionuclides in 50 packaged fruit juice samples from Türkiye and estimated negligible ingestion-related radiological hazards for children aged 5–15 years and adults despite elevated 228Ra relative to drinking-water guidance.
No therapeutic hypothesis is supported by this record; at most, the findings indirectly suggest that radionuclide monitoring could inform exposure-prevention or regulatory policies, but the estimated risks were below international safety thresholds and no pediatric cancer intervention was tested.
The study measured heavy metals in coastal waters of southeastern Bangladesh and used exposure-risk models to identify possible non-carcinogenic and carcinogenic concerns, with modeled susceptibility greater in children.
The record provides no therapeutic hypothesis or pediatric-oncology intervention; at most, its modeled childhood exposure risks could motivate environmental prevention and monitoring research, but any connection to pediatric cancer incidence or treatment outcomes is inferential and untested.
This case report describes a 7-year-old girl with histopathologically confirmed buccal mucosal lobular capillary haemangioma that was surgically excised without recurrence during six months of follow-up.
The record provides case-level evidence that local surgical excision can control a buccal LCH; it does not establish comparative efficacy, broader safety, a novel therapeutic strategy, or applicability to malignant pediatric disease.
This record reports a correction to a systematic review and meta-analysis concerning health-related quality of life among Chinese children and adolescents with cancer, but supplies no correction details or study findings.
No therapeutic hypothesis is supported by this correction record; at most, the underlying review could indirectly inform supportive-care priorities, but that is inference rather than evidence presented here.
This case report describes a 14-year-old boy with a small transverse-colon juvenile polyp whose histology unexpectedly showed rare osseous metaplasia after uncomplicated polypectomy.
The record provides no evidence for a therapeutic strategy; at most, it supports the hypothesis that recognizing osseous metaplasia in pediatric polyps could aid pathological classification or future surveillance research, but its prognostic and treatment implications remain unknown.
This case report describes an adult colon-cancer survivor who, after left hemicolectomy and approximately three years and five months of disease-free follow-up, had an uncomplicated pregnancy and term cesarean delivery of a healthy neonate.
The reported evidence shows reproductive feasibility in one carefully selected adult survivor; it supports the hypothesis that pregnancy may be possible after curative colon-cancer surgery and confirmed disease-free follow-up with multidisciplinary care, but it does not establish pregnancy safety, recurrence risk, or a therapeutic intervention.
This case report describes a newborn with a clinically diagnosed preputial cyst who was successfully treated by circumcision and discusses the lesion as a rare form of median raphe cyst.
Evidence: circumcision successfully treated the cyst in this single newborn, while the abstract states that surgical excision is generally the treatment of choice. Inference: recognition of this benign-appearing lesion could support appropriate local surgical management and avoid diagnostic confusion, but the record provides no pediatric-oncology therapeutic hypothesis or comparative evidence.
This record is a removal/retraction notice for an article concerning blinatumomab in pediatric high-risk B-cell precursor acute lymphoblastic leukemia and reports no evaluable study findings.
No therapeutic hypothesis can be supported from this record; although the removed article's title referenced blinatumomab, MRD response, safety, and survival, the supplied notice provides no underlying evidence and those title-level claims should not be interpreted as valid findings.
Using GLOBOCAN 2022 estimates, the study describes global and regional cancer incidence and mortality across sex and age bands, finding substantial geographic disparities and disproportionately high mortality in younger populations within transitioning regions.
The record provides no direct therapeutic evidence; it supports the inference that age-, sex-, and region-specific allocation of early-detection and treatment resources might reduce disparities, including those affecting younger patients, but this requires intervention-based testing.
Using GBD 2021 estimates for 204 countries and territories, the study reports rising global CNS cancer incidence and prevalence from 1990 to 2021, declining age-standardized DALY rates, substantial socioeconomic disparities, and scenario-based projections of future burden.
The record provides no evidence for a specific therapy; it supports the inference that directing diagnostic, treatment, survivorship, and health-system resources toward high-DALY and lower-SDI populations could help reduce inequities in CNS cancer outcomes, but this was not tested and pediatric-specific benefit is not demonstrated.
This Global Burden of Disease analysis reports increasing worldwide thyroid-cancer incidence, prevalence, deaths, DALYs, and socioeconomic inequalities from 1990 to 2021, with case counts projected to continue rising through 2045.
The evidence supports population growth, aging, and widening cross-country inequalities as contributors to thyroid-cancer burden; it is reasonable but untested to infer that more equitable resource allocation and cancer-control planning could improve outcomes, as no therapeutic or preventive intervention was evaluated.
This area-level composite topsoil study found differing urban and rural metal(loid) patterns around Leicester, with precautionary screening calculations indicating child hazard indices above unity mainly from arsenic but no measured human exposure, cancer outcome, or pediatric-oncology endpoint.
The record provides no therapeutic hypothesis or treatment evidence; at most, it supports the inference that confirmatory exposure assessment could identify environmental risk-management opportunities for children, but any relevance to cancer prevention is untested.
